Italy · Delayed Price · Currency is EUR Philogen Statistics
Total Valuation
Philogen has a market cap or net worth of EUR 918.41 million. The enterprise value is 550.12 million.
| Market Cap | 918.41M |
| Enterprise Value | 550.12M |
Important Dates
The next confirmed earnings date is Wednesday, September 23, 2026.
| Earnings Date | Sep 23, 2026 |
| Ex-Dividend Date | May 18, 2026 |
Share Statistics
Philogen has 40.28 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 28.91M |
| Shares Outstanding | 40.28M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.01% |
| Float | 10.75M |
Valuation Ratios
The trailing PE ratio is 4.00.
| PE Ratio | 4.00 |
| Forward PE | n/a |
| PS Ratio | 2.87 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 2.46 |
| P/FCF Ratio | 3.47 |
| P/OCF Ratio | 3.43 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.11, with an EV/FCF ratio of 2.08.
| EV / Earnings | 2.40 |
| EV / Sales | 1.72 |
| EV / EBITDA | 2.11 |
| EV / EBIT | 2.14 |
| EV / FCF | 2.08 |
Financial Position
The company has a current ratio of 7.76, with a Debt / Equity ratio of 0.03.
| Current Ratio | 7.76 |
| Quick Ratio | 7.69 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 776.27 |
Financial Efficiency
Return on equity (ROE) is 89.63% and return on invested capital (ROIC) is 4,072.59%.
| Return on Equity (ROE) | 89.63% |
| Return on Assets (ROA) | 53.02% |
| Return on Invested Capital (ROIC) | 4,072.59% |
| Return on Capital Employed (ROCE) | 66.56% |
| Weighted Average Cost of Capital (WACC) | 4.22% |
| Revenue Per Employee | 1.49M |
| Profits Per Employee | 1.07M |
| Employee Count | 214 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 12.72 |
Taxes
In the past 12 months, Philogen has paid 30.43 million in taxes.
| Income Tax | 30.43M |
| Effective Tax Rate | 11.70% |
Stock Price Statistics
The stock price has decreased by -13.99% in the last 52 weeks. The beta is -0.00, so Philogen's price volatility has been lower than the market average.
| Beta (5Y) | -0.00 |
| 52-Week Price Change | -13.99% |
| 50-Day Moving Average | 21.89 |
| 200-Day Moving Average | 22.54 |
| Relative Strength Index (RSI) | 57.41 |
| Average Volume (20 Days) | 18,934 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Philogen had revenue of EUR 319.73 million and earned 229.68 million in profits. Earnings per share was 5.70.
| Revenue | 319.73M |
| Gross Profit | 280.16M |
| Operating Income | 256.95M |
| Pretax Income | 260.11M |
| Net Income | 229.68M |
| EBITDA | 260.09M |
| EBIT | 256.95M |
| Earnings Per Share (EPS) | 5.70 |
Balance Sheet
The company has 379.22 million in cash and 10.93 million in debt, with a net cash position of 368.30 million or 9.14 per share.
| Cash & Cash Equivalents | 379.22M |
| Total Debt | 10.93M |
| Net Cash | 368.30M |
| Net Cash Per Share | 9.14 |
| Equity (Book Value) | 373.87M |
| Book Value Per Share | 9.28 |
| Working Capital | 346.59M |
Cash Flow
In the last 12 months, operating cash flow was 267.96 million and capital expenditures -3.39 million, giving a free cash flow of 264.57 million.
| Operating Cash Flow | 267.96M |
| Capital Expenditures | -3.39M |
| Depreciation & Amortization | 3.14M |
| Net Borrowing | -1.15M |
| Free Cash Flow | 264.57M |
| FCF Per Share | 6.57 |
Margins
Gross margin is 87.62%, with operating and profit margins of 80.36% and 71.83%.
| Gross Margin | 87.62% |
| Operating Margin | 80.36% |
| Pretax Margin | 81.35% |
| Profit Margin | 71.83% |
| EBITDA Margin | 81.35% |
| EBIT Margin | 80.36% |
| FCF Margin | 82.75% |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 3.07%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 3.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.05% |
| Shareholder Yield | 3.09% |
| Earnings Yield | 25.01% |
| FCF Yield | 28.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Philogen is 27.67, which is 20.04% higher than the current price. The consensus rating is "Buy".
| Price Target | 27.67 |
| Price Target Difference | 20.04% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -36.76% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Philogen has an Altman Z-Score of 12.79 and a Piotroski F-Score of 7.
| Altman Z-Score | 12.79 |
| Piotroski F-Score | 7 |